COVID-19

In this COVID-19 pandemic, Veredus has available resources to support you with meeting demands for clinical testing. Starting from viral RNA extraction to molecular assay for the detection of SARS-CoV-2, we introduce a comprehensive diagnostic solution. Alternatively, we can also support you with rapid detection using serological testing.  Bookmark this page for updates as we learn more about COVID-19, its impact and how Veredus can continue supporting you as the crisis continues.

Request a quotation today

 

Rapid Antibody Test

 

Diagnostic Kit for Antibody IgM/IgG of Novel Coronavirus COVID-19

This is a rapid serological test for the qualitative and differential detection of IgM and IgG antibodies against SARS-CoV-2 in human whole blood, serum or plasma, capable of providing test results as fast as 10 minutes to support triage and clinical decision.

  • Received Singapore Health Sciences Authority provisional authorization for In vitro Diagnostic (IVD) use in Singapore.
  • Available as CE-IVD.

Download the brochure on the Rapid Antibody Test

Rapid Antigen Test

 

SGTi-flex COVID-19 Ag

‘SGTi-flex COVID-19 Ag’ is a one step, rapid Immunochromatographic Assay for the qualitative detection of specific antigens belonging to SARS-CoV-2 present in human nasopharyngeal (or oropharyngeal) swab specimen.
• Specimen: Nasopharyngeal (or oropharyngeal) swab
• One Step, Fast results within 20 min
• Full package for the whole test procedure, No need for additional tool/device
– Swab
– Buffer
– Test Cassette
• Package: 25 tests

Extraction-free Kit

ZeroPrep™ Saliva Collection Kit

Intended Use

ZeroPrep™ Saliva Collection Kit is a specimen device intended for the collection of human saliva with the preservation buffer designed to protect and preserve viral RNA suitable for use directly in genetic and molecular diagnostic testing. This kit is compatible for use together with the VereRT™ ZeroPrep™ COVID-19 PCR Kit for the diagnosis of COVID-19.

ZeroPrep™ Saliva Collection Kit is registered as a Class A Medical Device with the Health Sciences Authority (HSA) Singapore.

Veredus is authorised to export ZeroPrep™ Saliva Collection Kit out of Singapore subject to the duties and obligations as stipulated in the Health Products Act and the Health Products (Medical Devices) Regulation 2010.

Compatibility
• VereRT™ ZeroPrep™ COVID-19 PCR Kit

Molecular Tests

 

VereRT™ COVID-19 PCR Kit

Intended Use

VereRT™ COVID-19 PCR Kit is a one-step Reverse Transcription Polymerase Chain Reaction (RT-PCR)-based In Vitro Diagnostic (IVD) COVID-19 test intended for the qualitative detection of nucleic acid belonging to SARS-CoV-2. This test is suitable for use with extracted viral RNA from nasopharyngeal swab specimen in transport media and the test results can be used as supplementary data for diagnosis. Negative result does not preclude SARS-CoV-2 infection and should not be used as a sole basis for treatment or other patient management decisions. Testing with VereRT™ COVID-19 PCR Kit is intended for use by trained laboratory professionals who are proficient in performing real-time RT-PCR assays.

VereRT™ COVID-19 PCR Kit is under Provisional Authorisation for IVD use issued by Health Sciences Authority (HSA) Singapore. Veredus is authorised to supply VereRT™ COVID-19 PCR Kit to the healthcare institutions, private hospitals, medical clinics or clinics laboratories under the PHMC Act (Cap. 248) for use on their patients. This kit is also CE-IVD marked and approved by Philippines FDA for IVD use.

Veredus is authorised to export VereRT™ COVID-19 PCR Kit out of Singapore subject to the duties and obligations as stipulated in the Health Products Act and the Health Products (Medical Devices) Regulation 2010.

Compatibility
• CommaXP® Virus DNA / RNA Extraction Kit
• QIAamp® Viral RNA Mini Kit

Gene Targets
• Dual N gene targets (FAM)
• Human RPP30 (HEX)

Sensitivity
• 2 viral RNA copies per test

Turnaround Time
• Approximately 90 mins

VereRT™ ZeroPrep™ COVID-19 PCR Kit

Intended Use

VereRT™ ZeroPrep™ COVID-19 PCR Kit is a one-step Reverse Transcription Polymerase Chain Reaction (RT-PCR)-based In Vitro Diagnostic (IVD) COVID-19 test intended for the qualitative detection of nucleic acid belonging to SARS-CoV-2.

This test is suitable for use directly from either (1) Viral Transport Media (VTM) / Universal Transport Media (UTM) containing nasopharyngeal swab specimen; OR (2) Human saliva specimen. Both specimen types do not require viral RNA extraction prior to testing and the test results can be used as supplementary data for diagnosis. Negative result does not preclude SARS-CoV-2 infection and should not be used as a sole basis for treatment or other patient management decisions. Testing with VereRT™ ZeroPrep™ COVID-19 PCR Kit is intended for use by trained laboratory professionals who are proficient in performing real-time RT-PCR assays.

VereRT™ ZeroPrep™ COVID-19 PCR Kit is under Provisional Authorisation for IVD use issued by Health Sciences Authority (HSA) Singapore. Veredus is authorised to supply VereRT™ ZeroPrep™ COVID-19 PCR Kit to the healthcare institutions, private hospitals, medical clinics or clinics laboratories under the PHMC Act (Cap. 248) for use on their patients. This kit is also CE-IVD marked.

Veredus is authorised to export VereRT™ ZeroPrep™ COVID-19 PCR Kit out of Singapore subject to the duties and obligations as stipulated in the Health Products Act and the Health Products (Medical Devices) Regulation 2010.

Compatibility
• VTM* / UTM* containing nasopharyngeal swab specimen
• Human saliva specimen collected using ZeroPrep™ Saliva Collection Kit
* validated with 5 different brands of VTM /UTM

Gene Targets
• Dual N gene targets (FAM)
• Human RPP30 (HEX)

Sensitivity
• 10 viral RNA copies per test

Turnaround Time
• Approximately 90 mins

VereCoV™ OneMix Detection Kit for VerePLEX™ Biosystem


Intended Use

VereCoV™ OneMix Detection Kit is a multiplex Reverse Transcription Polymerase Chain Reaction (RT-PCR)-based In Vitro Diagnostic (IVD) COVID-19 test intended for the qualitative detection of nucleic acid belonging to SARS-CoV-2. This test is for use in conjunction with VerePLEX™ Biosystem and the test results can be used as supplementary data for diagnosis. Negative result does not preclude SARS-CoV-2 infection and should not be used as a sole basis for treatment or other patient management decisions. Testing with VereCoV™ OneMix Detection Kit is intended for use by trained laboratory professionals who are proficient in using the VerePLEX™ Biosystem.

VereCoV™ OneMix Detection Kit is an improvement to VereCoV™ Detection Kit which is under Provisional Authorisation for IVD use issued by Health Sciences Authority (HSA) Singapore. This kit is also CE-IVD marked.

Compatibility
• CommaXP® Virus DNA / RNA Extraction Kit
• QIAamp® Viral RNA Mini Kit

Gene Targets
• ORF1ab
• Spike (S)
• Nucleocapsid (N)

Sensitivity
• 20 viral RNA copies per test

Turnaround Time
• Approximately 120 mins

 

As part of Singapore’s efforts to control and minimise the spread of COVID-19 amongst populations, the government established laboratory testing capabilities which made it mandatory for travellers at checkpoints coming into Singapore with clinical symptoms of respiratory illness and/or fever to provide nasal swab specimens for testing using VereCoV™ OneMix Detection Kit. Consequently, the government reported several imported cases of COVID-19 and containment actions were implemented swiftly.

Read the full story:

Channel News Asia – New COVID-19 test kits used to screen swab samples collected at Singapore checkpoints

Today – New COVID-19 test kit deployed at all Singapore checkpoints detects its first imported case

Watch the news commentary:

 

Request a quotation now